Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Jun 28, 2024
Open Peer Review Period: Jul 4, 2024 - Aug 29, 2024
Date Accepted: Jan 29, 2026
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

App-Based Training Module on Guiding Physicians’ Prescription for Antibiotic Treatment of Gonorrhea: Cluster Randomized Controlled Trial

Jiang TT, Zhang XB, Zhao PZ, Fei LJ, Chen HM, Yang YQ, Jia MH, Wang C, Shen YL, Xu YJ, Han Y, Yin YP, Chen XS

App-Based Training Module on Guiding Physicians’ Prescription for Antibiotic Treatment of Gonorrhea: Cluster Randomized Controlled Trial

JMIR Mhealth Uhealth 2026;14:e63736

DOI: 10.2196/63736

App-based training module on guiding physicians’ prescription for antibiotic treatment of gonorrhoea in China: cluster-randomised controlled trial

  • Ting-Ting Jiang; 
  • Xiao-Bin Zhang; 
  • Pei-Zhen Zhao; 
  • Li-Juan Fei; 
  • Hui-Min Chen; 
  • Yun-Qing Yang; 
  • Man-Hong Jia; 
  • Cheng Wang; 
  • Yun-Liang Shen; 
  • Yu-Jun Xu; 
  • Yan Han; 
  • Yue-Ping Yin; 
  • Xiang-Sheng Chen

ABSTRACT

Background:

High prevalence of physicians’ non-adherence to treatment recommendations for gonorrhoea is a concern in China and poor awareness of treatment recommendations has been documented as one of reasons for the non-adherence.

Objective:

To assess the impact of an App-based training tool on improvement of adherence to treatment recommendations for gonorrhoea in China.

Methods:

We did a cluster-randomised controlled trial. Clusters were hospitals from four provinces in China. We randomly allocated each hospital to receive an App-based training module (ATM) or continue the routine of training (ROT). In ATM hospitals, physicians were offered a free App-based training through their smartphones for access to the training anytime (intervention) for 6 months. In ROT hospitals, physicians participated in any training programmes as they routinely did (control). The primary outcome was comparison of changes in adherence rate between ATM and ROT. The secondary outcome was reasons for physicians to explain their non-adherence.

Results:

Among 72 hospitals from the 4 provinces (18 hospitals of each province), 36 each received ATM and ROT, respectively. Over 6 months, the adherence rate increased from 53.6% to 54.8% in ATM group while the rate decreased from 43.9% to 42.5% in ROT. The difference (5.5%, 95% CI -7-18, P=0.37) in changes of the adherence rate between ATM and ROT was not statistically significant (risk ratio 1.12, 95% CI 0.93- 1.35, P=0.23). A major reason for physicians’ non-adherence to the treatment recommendations was a concern on adequacy of the recommended dosage of currently available generic format of ceftriaxone for treatment of gonorrhoea in China.

Conclusions:

The findings indicate that sizeable improvement of adherence to the treatment recommendations through an App-based training tool might not be achievable over a 6-month period if concern on effectiveness of generic medicine still exits. Clinical Trial: https://www.chictr.org.cn/ ChiCTR2000029591


 Citation

Please cite as:

Jiang TT, Zhang XB, Zhao PZ, Fei LJ, Chen HM, Yang YQ, Jia MH, Wang C, Shen YL, Xu YJ, Han Y, Yin YP, Chen XS

App-Based Training Module on Guiding Physicians’ Prescription for Antibiotic Treatment of Gonorrhea: Cluster Randomized Controlled Trial

JMIR Mhealth Uhealth 2026;14:e63736

DOI: 10.2196/63736

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.